Skip to main content
Erschienen in: Esophagus 1/2019

01.01.2019 | Original Article

Inter-institutional variations regarding Barrett’s esophagus diagnosis

verfasst von: Norihisa Ishimura, Mika Yuki, Takafumi Yuki, Yoshinori Komazawa, Yoshinori Kushiyama, Hirofumi Fujishiro, Shunji Ishihara, Yoshikazu Kinoshita

Erschienen in: Esophagus | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Barrett’s esophagus (BE) is a known precursor for development of esophageal adenocarcinoma and surveillance of affected patients is necessary when cancer progression risk is considered to be high. However, the accuracy of BE diagnosis may not be homogenous among institutions with endoscopy units. We investigated inter-institutional variability by examining the accuracy of endoscopic diagnosis of BE at 4 different hospitals.

Methods

The accuracy of BE diagnosis at the 4 hospitals was retrospectively reviewed by 6 expert endoscopists, who independently reviewed endoscopic images of approximately 500 consecutive patients examined at each hospital without information regarding the diagnosis by the on-site endoscopists. When the expert reviewers made different diagnosis, a final diagnosis was made by consensus. That was then compared with the diagnosis of the attending endoscopists at each hospital and their concordance was calculated separately for each endoscopy unit. In addition, the relationship between diagnostic accuracy and endoscopic experience was assessed.

Results

The prevalence of BE diagnosis by the on-site endoscopists was not homogenous and varied widely (17.2–96.8%). In 1 hospital, over-diagnosis was the cause of dissimilarity, while under-diagnosis was the cause in two hospitals. Diagnostic accuracy by the attending endoscopists in all 4 hospitals ranged from 44.6 to 83.1% (P < 0.05). There was no significant association between diagnostic accuracy and endoscopic experience or board licensing status of the on-site endoscopists.

Conclusion

Diagnostic accuracy for BE was not homogenous among 4 hospitals, and problems related to over- and under-diagnosis should be considered.
Literatur
1.
Zurück zum Zitat Katanoda K, Hori M, Matsuda T, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Jpn J Clin Oncol. 2015;45:390–401.CrossRef Katanoda K, Hori M, Matsuda T, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Jpn J Clin Oncol. 2015;45:390–401.CrossRef
2.
Zurück zum Zitat Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types. Cancer Epidemiol. 2016;44:71–6.CrossRefPubMed Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types. Cancer Epidemiol. 2016;44:71–6.CrossRefPubMed
3.
Zurück zum Zitat Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.CrossRefPubMed Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.CrossRefPubMed
4.
Zurück zum Zitat Japanese Society of Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus. 2005;2:43–69.CrossRef Japanese Society of Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus. 2005;2:43–69.CrossRef
6.
Zurück zum Zitat de Jonge PJ, van Blankenstein M, Grady WM, et al. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191–202.CrossRefPubMed de Jonge PJ, van Blankenstein M, Grady WM, et al. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191–202.CrossRefPubMed
7.
Zurück zum Zitat Sami SS, Ragunath K, Iyer PG. Screening for Barrett’s esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol. 2015;13:623–34.CrossRefPubMed Sami SS, Ragunath K, Iyer PG. Screening for Barrett’s esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol. 2015;13:623–34.CrossRefPubMed
8.
Zurück zum Zitat Ishimura N, Amano Y, Kinoshita Y. Endoscopic definition of esophagogastric junction for diagnosis of Barrett’s esophagus: importance of systematic education and training. Dig Endosc. 2009;21:213–8.CrossRefPubMed Ishimura N, Amano Y, Kinoshita Y. Endoscopic definition of esophagogastric junction for diagnosis of Barrett’s esophagus: importance of systematic education and training. Dig Endosc. 2009;21:213–8.CrossRefPubMed
9.
Zurück zum Zitat Ishimura N, Amano Y, Sollano J, et al. Questionnaire-based survey conducted in 2011 concerning endoscopic management of barrett’s esophagus in East Asian countries. Digestion. 2012;86:136–46.CrossRefPubMed Ishimura N, Amano Y, Sollano J, et al. Questionnaire-based survey conducted in 2011 concerning endoscopic management of barrett’s esophagus in East Asian countries. Digestion. 2012;86:136–46.CrossRefPubMed
10.
Zurück zum Zitat Scholvinck D, Goto O, Seldenrijk CA, et al. Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population. J Gastroenterol. 2016;51:682–90.CrossRefPubMed Scholvinck D, Goto O, Seldenrijk CA, et al. Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population. J Gastroenterol. 2016;51:682–90.CrossRefPubMed
11.
Zurück zum Zitat Amano Y, Ishimura N, Furuta K, et al. Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc. 2006;64:206–11.CrossRefPubMed Amano Y, Ishimura N, Furuta K, et al. Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc. 2006;64:206–11.CrossRefPubMed
12.
Zurück zum Zitat Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.CrossRef Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.CrossRef
13.
Zurück zum Zitat Pohl H, Pech O, Arash H, et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65:196–201.CrossRef Pohl H, Pech O, Arash H, et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65:196–201.CrossRef
14.
Zurück zum Zitat Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11:1430–6.CrossRef Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11:1430–6.CrossRef
15.
Zurück zum Zitat Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50.CrossRef Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50.CrossRef
16.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRef Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRef
17.
Zurück zum Zitat Japan Esocphageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.CrossRef Japan Esocphageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.CrossRef
18.
Zurück zum Zitat Amano Y, Kinoshita Y. Barrett esophagus: perspectives on its diagnosis and management in asian populations. Gastroenterol Hepatol (N Y). 2008;4:45–53. Amano Y, Kinoshita Y. Barrett esophagus: perspectives on its diagnosis and management in asian populations. Gastroenterol Hepatol (N Y). 2008;4:45–53.
19.
Zurück zum Zitat Sugimoto H, Kawai T, Naito S, et al. Surveillance of short-segment Barrett’s esophagus using ultrathin transnasal endoscopy. J Gastroenterol Hepatol. 2015;30(Suppl 1):41–5.CrossRefPubMed Sugimoto H, Kawai T, Naito S, et al. Surveillance of short-segment Barrett’s esophagus using ultrathin transnasal endoscopy. J Gastroenterol Hepatol. 2015;30(Suppl 1):41–5.CrossRefPubMed
20.
Zurück zum Zitat Ganz RA, Allen JI, Leon S, et al. Barrett’s esophagus is frequently overdiagnosed in clinical practice: results of the Barrett’s Esophagus Endoscopic Revision (BEER) study. Gastrointest Endosc. 2014;79:565–73.CrossRefPubMed Ganz RA, Allen JI, Leon S, et al. Barrett’s esophagus is frequently overdiagnosed in clinical practice: results of the Barrett’s Esophagus Endoscopic Revision (BEER) study. Gastrointest Endosc. 2014;79:565–73.CrossRefPubMed
21.
Zurück zum Zitat Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–31.CrossRef Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–31.CrossRef
23.
Zurück zum Zitat Aida J, Vieth M, Ell C, et al. Palisade vessels as a new histologic marker of esophageal origin in ER specimens from columnar-lined esophagus. Am J Surg Pathol. 2011;35:1140–5.CrossRefPubMed Aida J, Vieth M, Ell C, et al. Palisade vessels as a new histologic marker of esophageal origin in ER specimens from columnar-lined esophagus. Am J Surg Pathol. 2011;35:1140–5.CrossRefPubMed
24.
Zurück zum Zitat Kumagai Y, Yagi M, Aida J, et al. Detailed features of palisade vessels as a marker of the esophageal mucosa revealed by magnifying endoscopy with narrow band imaging. Dis Esophagus. 2012;25:484–90.CrossRefPubMed Kumagai Y, Yagi M, Aida J, et al. Detailed features of palisade vessels as a marker of the esophageal mucosa revealed by magnifying endoscopy with narrow band imaging. Dis Esophagus. 2012;25:484–90.CrossRefPubMed
25.
Zurück zum Zitat El-Serag HB, Naik AD, Duan Z, et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut. 2016;65:1252–60.CrossRef El-Serag HB, Naik AD, Duan Z, et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut. 2016;65:1252–60.CrossRef
26.
Zurück zum Zitat Qiao Y, Hyder A, Bae SJ, et al. Surveillance in patients with Barrett’s esophagus for early detection of esophageal adenocarcinoma: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2015;6:e131.CrossRefPubMedPubMedCentral Qiao Y, Hyder A, Bae SJ, et al. Surveillance in patients with Barrett’s esophagus for early detection of esophageal adenocarcinoma: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2015;6:e131.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kestens C, Offerhaus GJ, van Baal JW, et al. Patients With Barrett’s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol. 2016;14:956–62.CrossRefPubMed Kestens C, Offerhaus GJ, van Baal JW, et al. Patients With Barrett’s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol. 2016;14:956–62.CrossRefPubMed
28.
Zurück zum Zitat Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRef Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRef
29.
Zurück zum Zitat Takubo K, Aida J, Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol. 2009;40:65–74.CrossRefPubMed Takubo K, Aida J, Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol. 2009;40:65–74.CrossRefPubMed
30.
Zurück zum Zitat Chang J, Fasanella K, Chennat J, et al. Prevalence of esophageal neoplasia in short-segment versus long-segment Barrett’s esophagus. Esophagus. 2016;13:151–5.CrossRef Chang J, Fasanella K, Chennat J, et al. Prevalence of esophageal neoplasia in short-segment versus long-segment Barrett’s esophagus. Esophagus. 2016;13:151–5.CrossRef
Metadaten
Titel
Inter-institutional variations regarding Barrett’s esophagus diagnosis
verfasst von
Norihisa Ishimura
Mika Yuki
Takafumi Yuki
Yoshinori Komazawa
Yoshinori Kushiyama
Hirofumi Fujishiro
Shunji Ishihara
Yoshikazu Kinoshita
Publikationsdatum
01.01.2019
Verlag
Springer Singapore
Erschienen in
Esophagus / Ausgabe 1/2019
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-018-0631-y

Weitere Artikel der Ausgabe 1/2019

Esophagus 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.